BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 617295)

  • 21. [Clinical and electrocardiographic evaluation of the effects of nifedipine in ischemic cardiopathy with the stenocardiac syndrome].
    Mastrocola C; Baratta L; Tubani L; Vittori G; Petrosillo N; Avella A
    Boll Soc Ital Cardiol; 1978; 23(10):1721-5. PubMed ID: 122222
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of nifedipine on the response to exertion and on peripheral tissue oxygenation. Comparative study of healthy individuals and coronary insufficiency patients].
    Botas L; Freitas JP; Barroca JP; Proenca C; Pereira JM; Martins e Silva JA
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II75-81. PubMed ID: 6763270
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of nifedipine, a calcium antagonist, on the ECG aspects of ischemic myocardiopathy].
    Alfano G; Melandri F; Moracchini PV; De Gesu R; Boschi S
    Boll Soc Ital Cardiol; 1978; 23(8):1394-401. PubMed ID: 549625
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in left ventricular dynamics caused by calcium antagonists].
    Binaghi G; Arancio F; Boscarini M; Verna E; Repetto S
    Boll Soc Ital Cardiol; 1978; (1 Suppl):105-13. PubMed ID: 757674
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effects of treatment with trapidil compared to nifedipine on physical, emotional and cognitive exercise tolerance in patients with coronary heart disease].
    Assmann I; Lehrl S; Burkard G; Strösser W
    Arzneimittelforschung; 1996 Sep; 46(9):868-74. PubMed ID: 8967905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
    Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of calcium antagonists on left ventricular systolic time intervals in patients with artificial pacemakers].
    Campa PP; Speca G; De Curtis G; Pecce P
    Boll Soc Ital Cardiol; 1979; 24(6):617-9. PubMed ID: 551794
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of nifedipine during rehabilitation of patients with aortocoronary bypass].
    Cerri B; Grasso S; Buonomini G; Cefis M; Costanza G; Pesciatini F
    Minerva Cardioangiol; 1981 Sep; 29(9):483-90. PubMed ID: 6975900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary clinical evaluation of the use of nifedipine].
    De Pasquale B; Bossa P
    Boll Soc Ital Cardiol; 1978; 23(10):1735-7. PubMed ID: 261837
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular effects of nifedipine--a 4-week treatment in preselected patients with coronary disease.
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):122-7. PubMed ID: 7068285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical observations on the treatment of ischemic cardiac disease with a calcium antagonist: nifedipine].
    Bufalini AA; Bargero G; Botta M; Marzani MC; Montalenti P; Navazzotti R; Piccolini E; Marzani PC
    Arch Sci Med (Torino); 1980; 137(4):715-24. PubMed ID: 7247695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of korinfar in the early stages of heart failure in ischemic heart disease].
    Goncharova LN; Danilova IV
    Sov Med; 1987; (12):85-8. PubMed ID: 3445181
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of nifedipin on blood pressure and systolic time intervals in hypertensives and normotensives (author's transl)].
    Ressl J; Frídl P
    Cas Lek Cesk; 1981 Sep; 120(35):1045-50. PubMed ID: 7273070
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism if action of calcium antagonists (nifedipine) and their value in the treatment of ischemic coronary diseases].
    Accardo G; Pazzi A; Bernardoni R
    G Clin Med; 1981 Jan; 62(1):45-50. PubMed ID: 7227709
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of intencordin on the phase structure of the systole of left ventricle and amino acid content of blood serum in ischemic heart disease].
    Todosienko LA
    Vrach Delo; 1979 Jan; (1):16-21. PubMed ID: 425457
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of kinilentin on phase structure of left ventricular systole and hemodynamic parameters].
    Pashchenko LS; Zapevina VV; Poliakova LA; Nikolaeva SA
    Sov Med; 1989; (12):125-6. PubMed ID: 2631239
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electrocardiographic changes in myocardial damage; effect of treatment with nifedipine].
    Del Guercio R; Gentile S
    Clin Ter; 1981 Jan; 96(2):163-73. PubMed ID: 7237951
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
    Novo S; Riolo F; Pinto A; Davì G; Botindari C
    Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute changes in the mechanical function of the ischemic left ventricle induced with perlingual nifedipine. Preliminary report].
    Trevi GP; Sheiban I; Benussi P; Marini A; Dal Forno P
    Boll Soc Ital Cardiol; 1978; (1 Suppl):161-70. PubMed ID: 757678
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure.
    Ludbrook PA; Tiefenbrunn AJ; Sobel BE
    Am J Med; 1981 Oct; 71(4):683-92. PubMed ID: 7282756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.